Mark J. Holdbrook, V.P, Clinical Affairs at Tarsus Pharmaceuticals, Inc. (TARS), sold 187 shares at $13.43 ($3K) on 2023-03-16, disclosed to the SEC on 2023-03-17.
Open-market sale of $3k TARS by V.P, Clinical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.